Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL1933180 | 0.89 | TSHR (0.62) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL4214652 | 0.89 | TSHR (0.62) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Cadaverine Tartrate SCHEMBL6560274 | 0.87 | TSHR (0.59) | TSHRALDH1A1PDE4AOR51E2CYP2C9 | |
| Butanedione SCHEMBL2913079 | 0.87 | LMNA (0.60) | TSHRLMNAALDH1A1OR51E2THPO | |
| Cadaverine Tartrate SCHEMBL42202 | 0.84 | TSHR (0.71) | TSHRPDE4AOR51E2CYP2C9THPO | |
| Glycerin SCHEMBL23675030 | 0.81 | LMNA (0.53) | TSHRLMNAALDH1A1OR51E2TP53 | |
| Pyruvate SCHEMBL2052994 | 0.81 | LMNA (0.53) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Pyruvate SCHEMBL30531673 | 0.81 | LMNA (0.53) | TSHRLMNAALDH1A1PDE4AOR51E2 | |
| Glycerin SCHEMBL27617095 | 0.81 | LMNA (0.53) | TSHRLMNAALDH1A1OR51E2TP53 | |
| Glycerin SCHEMBL1840579 | 0.81 | LMNA (0.53) | TSHRLMNAALDH1A1OR51E2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023190295-A1 | LIQUID NUTRITIONAL COMPOSITION AND PACKAGE | ニュートリー株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-113875867-A | Milk-containing coffee beverage and preparation method thereof | 广州市东鹏食品饮料有限公司 | 2022-01-04 | — | — | CN | claimed |
| CN-106068080-A | Beverage emulsifying agent containing milk composition | 理研维他命股份有限公司 | 2016-11-02 | — | — | CN | claimed |
| CN-103432091-A | Improved-performance tablet and preparation method thereof | ZHONG SHUGUANG | 2013-12-11 | — | — | CN | claimed |
| WO-2010112965-A1 | ISOLATION COATING OF DICLOFENAC TABLETS | ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI (TR) | 2010-10-07 | — | — | WO | claimed |
| CN-1891080-A | Meat quality-improving agent | RIKEN VITAMIN CO (JP) | 2007-01-10 | — | — | CN | claimed |
| US-6818244-B2 | LOW-TEMPERATURE, HIGH SPEED REACTION OF A DIACETYLATED TARTARIC ACID ANHYDRIDE MELT AND A MELT OF PARTIAL GLYCERIDES COMPRISING 60-99% MONOGLYCERIDES; EMULSIFIER, DOUGH CONDITIONER FOR FLOUR AND YEAST-LEAVENED BAKERY GOODS | QUEST INTERNATIONAL B.V. (NL) | 2004-11-16 | — | — | US | claimed |
| US-6642278-B1 | Emulsifiers, dough conditioning, baked goods | QUEST INTERNATIONAL B.V. (NL) | 2003-11-04 | — | — | US | claimed |
| US-6635299-B1 | Emulsifier for baked goods | QUEST INTERNATIONAL B.V. (NL) | 2003-10-21 | — | — | US | claimed |
| US-20030162893-A1 | Diacetyl tartaric acid esters of mono- and dig1ycerides based on C12 to C22 fatty acids | QUEST INTERNATIONAL B.V. (NL) | 2003-08-28 | — | — | US | claimed |
| EP-1016647-B1 | Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids | QUEST INT (NL) | 2003-05-28 | — | — | EP | claimed |
| WO-2000040542-A1 | DIACETYL TARTARIC ACID ESTERS OF MONO- AND DIGLYCERIDES BASED ON C12 TO C22 FATTY ACIDS | QUEST INTERNATIONAL B.V. (NL) | 2000-07-13 | — | — | WO | claimed |
| EP-1016647-A1 | Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids | QUEST INTERNATIONAL B.V. (NL) | 2000-07-05 | — | — | EP | claimed |
| WO-2024071966-A1 | COMPOSITION FOR DELAYING RANCIDITY OF OIL AND OILS COMPRISING SAME | 씨제이제일제당 (주) | 2024-04-04 | — | — | WO | disclosed |
| EP-3589280-B1 | FORMULATIONS WITH IMPROVED STABILITY | INSPIRNA INC (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240025870-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | Synaptogenix, Inc. (US) | 2024-01-25 | — | — | US | disclosed |
| WO-2000040542-A1 | DIACETYL TARTARIC ACID ESTERS OF MONO- AND DIGLYCERIDES BASED ON C12 TO C22 FATTY ACIDS | QUEST INTERNATIONAL B.V. (NL) | 2000-07-13 | — | — | WO | disclosed |
| EP-1016647-A1 | Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids | QUEST INTERNATIONAL B.V. (NL) | 2000-07-05 | — | — | EP | disclosed |
| EP-1016647-A1 | Diacetyl tartaric acid esters of mono- and diglycerides based on C12 to C22 fatty acids | QUEST INTERNATIONAL B.V. (NL) | 2000-07-05 | — | — | EP | disclosed |
| JP-2000060495-A | OIL OR FAT COMPOSITION FOR PROCESSED FISH FOOD AND PROCESSED FISH FOOD | RIKEN VITAMIN CO LTD | 2000-02-29 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240025870-A1 | PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | PRKCH, PRKCA, PRKCG | GBA1 440/4885TSHR 4318/4885LMNA 1532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.